Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 4
2011 2
2012 1
2015 1
2018 3
2019 5
2020 7
2021 12
2022 22
2023 12
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Hemorrhagic disorders of fibrinolysis: a clinical review.
Saes JL, Schols SEM, van Heerde WL, Nijziel MR. Saes JL, et al. Among authors: schols sem. J Thromb Haemost. 2018 May 30. doi: 10.1111/jth.14160. Online ahead of print. J Thromb Haemost. 2018. PMID: 29847021 Free article. Review.
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.
Atiq F, Blok R, van Kwawegen CB, Doherty D, Lavin M, van der Bom JG, O'Connell NM, de Meris J, Ryan K, Schols SEM, Byrne M, Heubel-Moenen FCJI, van Galen KPM, Preston RJS, Cnossen MH, Fijnvandraat K, Baker RI, Meijer K, James P, Di Paola J, Eikenboom J, Leebeek FWG, O'Donnell JS. Atiq F, et al. Among authors: schols sem. Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457. Blood. 2024. PMID: 38142407 Free PMC article.
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab.
Wijnsma KL, Ter Heine R, Moes DJAR, Langemeijer S, Schols SEM, Volokhina EB, van den Heuvel LP, Wetzels JFM, van de Kar NCAJ, Brüggemann RJ. Wijnsma KL, et al. Among authors: schols sem. Clin Pharmacokinet. 2019 Jul;58(7):859-874. doi: 10.1007/s40262-019-00742-8. Clin Pharmacokinet. 2019. PMID: 30758736 Free PMC article. Review.
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
Oomen I, Verhagen M, Miranda M, Allacher P, Beckers EAM, Blijlevens NMA, van der Bom JG, Coppens M, Driessens M, Eikenboom JCJ, Fijnvandraat K, Hassan S, van Heerde WL, Hooimeijer HL, Jansen JH, Kaijen P, Leebeek FWG, Meijer D, Paul H, Rijpma SR, Rosendaal FR, Smit C, van Vulpen LFD, Voorberg J, Schols SEM, Gouw SC. Oomen I, et al. Among authors: schols sem. Front Immunol. 2024 Feb 22;15:1355813. doi: 10.3389/fimmu.2024.1355813. eCollection 2024. Front Immunol. 2024. PMID: 38455035 Free PMC article.
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients.
Swinkels M, Atiq F, Bürgisser PE, van Moort I, Meijer K, Eikenboom J, Fijnvandraat K, van Galen KPM, de Meris J, Schols SEM, van der Bom JG, Cnossen MH, Voorberg J, Leebeek FWG, Bierings R, Jansen AJG; WiN study group. Swinkels M, et al. Among authors: schols sem. Br J Haematol. 2022 May;197(4):497-501. doi: 10.1111/bjh.18145. Epub 2022 Mar 22. Br J Haematol. 2022. PMID: 36165954 Free PMC article.
Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM. Maas DPMSM, et al. Among authors: schols sem. J Thromb Haemost. 2022 Feb;20(2):316-327. doi: 10.1111/jth.15586. Epub 2021 Nov 21. J Thromb Haemost. 2022. PMID: 34758185 Free PMC article.
75 results